World's Best Scientists 2026 revealed!
VIEW LIST
Jeffrey S. Weber

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 128 2637 2459 1476 1355 598 108643

Jeffrey S. Weber publications per year

The chart shows the history of publications by Jeffrey S. Weber between 1987 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Jeffrey S. Weber published across 40 years, from 1987 to 2026, averaging 23.5 papers a year. Output peaked at 250 publications in 2023. 24 of the 940 publications appeared in the last two years.

No. of publications
50 100 150 200 250
Bar chart. Horizontal axis: year, 1987 to 2026. Vertical axis: number of publications, 0 to 250. Peak 250 publications in 2023. 1987: 1 publication 1988: 0 publications 1989: 1 publication 1990: 1 publication 1991: 0 publications 1992: 4 publications 1993: 5 publications 1994: 7 publications 1995: 4 publications 1996: 0 publications 1997: 0 publications 1998: 0 publications 1999: 5 publications 2000: 1 publication 2001: 6 publications 2002: 5 publications 2003: 7 publications 2004: 14 publications 2005: 13 publications 2006: 12 publications 2007: 12 publications 2008: 18 publications 2009: 16 publications 2010: 15 publications 2011: 28 publications 2012: 37 publications 2013: 32 publications 2014: 36 publications 2015: 44 publications 2016: 46 publications 2017: 35 publications 2018: 34 publications 2019: 34 publications 2020: 44 publications 2021: 33 publications 2022: 35 publications 2023: 250 publications 2024: 81 publications 2025: 23 publications 2026: 1 publication
1987 2026

940 publications in total across all disciplines

View publications per year as a table
Jeffrey S. Weber: publications per year, 1987 to 2026
Year Publications
1987 1
1988 0
1989 1
1990 1
1991 0
1992 4
1993 5
1994 7
1995 4
1996 0
1997 0
1998 0
1999 5
2000 1
2001 6
2002 5
2003 7
2004 14
2005 13
2006 12
2007 12
2008 18
2009 16
2010 15
2011 28
2012 37
2013 32
2014 36
2015 44
2016 46
2017 35
2018 34
2019 34
2020 44
2021 33
2022 35
2023 250
2024 81
2025 23
2026 1
Total 940
Download as CSV

Jeffrey S. Weber publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jeffrey S. Weber sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 581–600 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 598 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509 598
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Jeffrey S. Weber D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey S. Weber sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 128–129 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 128 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230 128
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Jeffrey S. Weber is affiliated with New York University in the United States and has contributed extensively to the field of medicine, with a primary focus on oncology. Their research spans a range of subfields including molecular biology, immunology, cancer research, and pulmonary and respiratory medicine.

The scientist's recent publications reflect their ongoing work in cancer immunotherapy, particularly in melanoma treatment and immune response. Selected recent papers include:

  • Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study (2024, The Lancet)
  • Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial (2020, The Lancet Oncology)
  • Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma (2021, Journal of Clinical Oncology)
  • Systemic Therapy for Melanoma: ASCO Guideline (2020, Journal of Clinical Oncology)
  • Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies (2021, Nature Reviews Drug Discovery)

Their frequent coauthors include:

  • Paolo A. Ascierto
  • Georgina V. Long
  • James Larkin
  • Iman Osman
  • Omid Hamid

Geographically and institutionally embedded in the United States, Jeffrey S. Weber has published most prolifically in several key journals:

  • Journal of Clinical Oncology
  • Journal for ImmunoTherapy of Cancer
  • Clinical Cancer Research
  • Cancer Research
  • Regular and Young Investigator Award Abstracts

The main research topics covered in their work include:

  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Cutaneous Melanoma Detection and Management
  • Melanoma and MAPK Pathways
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies

Their publications consistently contribute to understanding the mechanisms and treatment options for melanoma and other cancers, often emphasizing immune-based therapies and personalized medicine approaches. The scientist's research outputs are reflected in high citation counts and ongoing collaborations that link clinical oncology, immunotherapy, and translational research.

Best Publications

  • Improved Survival with Ipilimumab in Patients with Metastatic Melanoma.

    F. Stephen Hodi;Steven J. O'Day;David F. McDermott;Robert W. Weber

  • Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

    Caroline Robert;Luc Thomas;Igor Bondarenko;Steven O'Day

  • Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

    Omid Hamid;Caroline Robert;Adil Daud;F. Stephen Hodi

  • Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

    Julie R. Brahmer;Christina Lacchetti;Bryan J. Schneider;Michael B. Atkins

  • Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

    Jedd D. Wolchok;Axel Hoos;Steven O'Day;Jeffrey S. Weber

  • Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

    Keith T. Flaherty;Jeffery R. Infante;Adil Daud;Rene Gonzalez

  • Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

    Jeffrey S Weber;Sandra P D'Angelo;David Minor;F Stephen Hodi

  • Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

    Jeffrey A. Sosman;Kevin B. Kim;Lynn Schuchter;Rene Gonzalez

  • Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

    Dirk Schadendorf;F. Stephen Hodi;Caroline Robert;Jeffrey S. Weber

  • Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

    Jeffrey Weber;Mario Mandala;Michele Del Vecchio;Helen J. Gogas

  • Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial

    Caroline Robert;Antoni Ribas;Jedd D. Wolchok;F. Stephen Hodi

  • Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab

    Jeffrey S. Weber;Katharina C. Kähler;Axel Hauschild

  • Treatment of 283 Consecutive Patients With Metastatic Melanoma or Renal Cell Cancer Using High-Dose Bolus Interleukin 2

    Steven A. Rosenberg;James C. Yang;Suzanne L. Topalian;Douglas J. Schwartzentruber

  • Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

    Alexander M M Eggermont;Vanna Chiarion-Sileni;Jean-Jacques Grob;Reinhard Dummer

  • Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.

    Peter P. Lee;Cassian Yee;Peter A. Savage;Lawrence Fong

  • Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

    Alexander M M Eggermont;Vanna Chiarion-Sileni;Jean Jacques Grob;Reinhard Dummer

  • Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2

    Steven A. Rosenberg;John R. Yannelli;James C. Yang;Suzanne L. Topalian

  • Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma.

    Jeffrey S. Weber;F. Stephen Hodi;Jedd D. Wolchok;Suzanne L. Topalian

  • Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

    Antoni Ribas;Omid Hamid;Adil Daud;F. Stephen Hodi

  • Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes

    Morganna Freeman-Keller;Youngchul Kim;Heather Cronin;Allison Richards

Frequent Co-Authors

Omid Hamid
Omid Hamid Cedars-Sinai Medical Center
F. Stephen Hodi
F. Stephen Hodi Harvard University
Jedd D. Wolchok
Jedd D. Wolchok Cornell University
Caroline Robert
Caroline Robert University of Paris-Saclay
Paolo A. Ascierto
Paolo A. Ascierto National Institutes of Health
Adil Daud
Adil Daud University of California, San Francisco
Antoni Ribas
Antoni Ribas University of California, Los Angeles
Vernon K. Sondak
Vernon K. Sondak University of South Florida
Richard F. Kefford
Richard F. Kefford Macquarie University
Mario Sznol
Mario Sznol Yale University

External Links

Personal website of Jeffrey S. Weber

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean attending medical school. There are flexible alternatives to get started or advance in healthcare, especially with today’s online degree options. Many professionals begin as licensed practical nurses. If you’re looking for an entry point, consider enrolling in a lpn program online to fast-track your way into the field.

If you’re already an RN and want to earn your bachelor’s, there are now rn to bsn programs no clinicals, allowing you to further your education from home with minimal on-site requirements.

For nurses aiming for the highest level of clinical practice, accelerated dnp programs can help you earn a doctorate quickly. Additionally, some online dnp programs without dissertation make it more accessible for working nurses to advance without the challenge of lengthy research projects.

Each pathway provides unique opportunities, letting you tailor your medical career to your goals, background, and schedule.

Best Scientists Citing Jeffrey S. Weber

Jedd D. Wolchok

Jedd D. Wolchok

Cornell University

Publications: 189

Georgina V. Long

Georgina V. Long

University of Sydney

Publications: 177

Paolo A. Ascierto

Paolo A. Ascierto

National Institutes of Health

Publications: 147

Dirk Schadendorf

Dirk Schadendorf

University of Duisburg-Essen

Publications: 143

Caroline Robert

Caroline Robert

University of Paris-Saclay

Publications: 136

F. Stephen Hodi

F. Stephen Hodi

Harvard University

Publications: 126

Michael A. Postow

Michael A. Postow

Memorial Sloan Kettering Cancer Center

Publications: 124

Alexander M. Menzies

Alexander M. Menzies

University of Sydney

Publications: 118

Richard A. Scolyer

Richard A. Scolyer

Royal Prince Alfred Hospital

Publications: 101

Reinhard Dummer

Reinhard Dummer

University of Zurich

Publications: 95

Antoni Ribas

Antoni Ribas

University of California, Los Angeles

Publications: 93

Alexander M.M. Eggermont

Alexander M.M. Eggermont

Institut Gustave Roussy

Publications: 93

Douglas B. Johnson

Douglas B. Johnson

Vanderbilt University Medical Center

Publications: 91

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 89

John F. Thompson

John F. Thompson

University of Sydney

Publications: 87

Matteo S. Carlino

Matteo S. Carlino

University of Sydney

Publications: 86

Trending Scientists

Zhi-jun Li

Zhi-jun Li

Chinese Academy of Sciences

Volker Ribitsch

Volker Ribitsch

University of Graz

Casey M. Owens

Casey M. Owens

University of Arkansas at Fayetteville

Marilyn E. Scott

Marilyn E. Scott

McGill University

Janusz J. Zwiazek

Janusz J. Zwiazek

University of Alberta

Gar W. Rothwell

Gar W. Rothwell

Ohio University

Jong-Gwan Yook

Jong-Gwan Yook

Yonsei University

Paul Vedder

Paul Vedder

Leiden University

Willard S. Moore

Willard S. Moore

University of South Carolina

Robert S. Detrick

Robert S. Detrick

Woods Hole Oceanographic Institution

Ellen Nolte

Ellen Nolte

London School of Hygiene & Tropical Medicine

Bart Peeters

Bart Peeters

Siemens (Belgium)

Alberto Del Bimbo

Alberto Del Bimbo

University of Florence

Alison E. Ashcroft

Alison E. Ashcroft

University of Leeds

Günther H.J. Peters

Günther H.J. Peters

Technical University of Denmark

Scott J. Weisbenner

Scott J. Weisbenner

University of Illinois at Urbana-Champaign

Related Medicine Rankings & Guides

2027 Best Online DNP Programs

2027 Best Online DNP Programs
2027 Most Affordable Online Medical Billing and Coding Courses

2027 Most Affordable Online Medical Billing and Coding Courses
2027 Most Affordable Online Licensed Practical Nurse (LPN) Programs

2027 Most Affordable Online Licensed Practical Nurse (LPN) Programs
2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs
2027 Most Affordable Online Direct Entry MSN Programs for Non-Nurses

2027 Most Affordable Online Direct Entry MSN Programs for Non-Nurses
2027 Best Paramedic-to-RN Bridge Programs

2027 Best Paramedic-to-RN Bridge Programs
2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus

2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus
2027 Best Online MSN in Forensic Nursing Programs

2027 Best Online MSN in Forensic Nursing Programs
2027 Best Online Nursing Programs in Florida – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Florida – Accredited RN to BSN Programs
2027 Most Affordable Online LPN to RN Degree Programs

2027 Most Affordable Online LPN to RN Degree Programs
2027 Best Nurse Practitioner Programs in California – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in California – Accredited Schools Online & Campus
2027 Best Online Adult-Gerontology ACNP Graduate Certificate Programs

2027 Best Online Adult-Gerontology ACNP Graduate Certificate Programs
2027 Fastest Online Pharmacy Technician Certificate Programs

2027 Fastest Online Pharmacy Technician Certificate Programs
2027 Best Nurse Practitioner Programs in Arizona – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Arizona – Accredited Schools Online & Campus
2027 Best Online Nursing Programs in Maine – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Maine – Accredited RN to BSN Programs
2027 Most Affordable Online BSN to MSN Bridge Programs

2027 Most Affordable Online BSN to MSN Bridge Programs
September 2027 Best Online Kinesiology Programs

September 2027 Best Online Kinesiology Programs
2027 Best Online MSN Family Nurse Practitioner Programs

2027 Best Online MSN Family Nurse Practitioner Programs
2027 Most Affordable Online Master's Degrees in Nutrition

2027 Most Affordable Online Master's Degrees in Nutrition
2027 Best Occupational Therapy Programs

2027 Best Occupational Therapy Programs
2027 Best Online Master of Health Administration (MHA) Programs

2027 Best Online Master of Health Administration (MHA) Programs

Recently Published Articles

2027 Military-Friendly Online Nursing Education Degree Programs: Benefits, Accreditation, and Career Outcomes

2027 Military-Friendly Online Nursing Education Degree Programs: Benefits, Accreditation, and Career Outcomes
2027 Online Doctor of Education (EdD) Programs with No Residency Requirement

2027 Online Doctor of Education (EdD) Programs with No Residency Requirement
2027 Best Online Nursing Programs in Hawaii – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Hawaii – Accredited RN to BSN Programs
2027 Best Online Degrees at Concorde Career College - Dallas: Programs, Tuition, and Admissions

2027 Best Online Degrees at Concorde Career College - Dallas: Programs, Tuition, and Admissions
2027 Psychiatric Mental Health Nurse Practitioner ROI by Institution Type: Public vs Private vs Nonprofit Online Programs

2027 Psychiatric Mental Health Nurse Practitioner ROI by Institution Type: Public vs Private vs Nonprofit Online Programs
2027 Animation Careers: Guide to Career Path, Options & Salary

2027 Animation Careers: Guide to Career Path, Options & Salary
2027 Online Respiratory Care Therapy Bachelor's Degree Programs With No Prerequisites

2027 Online Respiratory Care Therapy Bachelor's Degree Programs With No Prerequisites
2027 Different Types of Business Law Degrees and Their Salaries

2027 Different Types of Business Law Degrees and Their Salaries
2027 Work Experience Requirements for Mental Health Counseling Degree Programs

2027 Work Experience Requirements for Mental Health Counseling Degree Programs
2027 Can You Complete an Online Radiology Technician Degree Program While Working Full-Time?

2027 Can You Complete an Online Radiology Technician Degree Program While Working Full-Time?
2027 Cybersecurity Degree Programs With Rolling Admissions

2027 Cybersecurity Degree Programs With Rolling Admissions
2027 Best Online Health Informatics Programs

2027 Best Online Health Informatics Programs
2027 MSW Admissions Interview Questions and How to Answer Them

2027 MSW Admissions Interview Questions and How to Answer Them
2027 How to Become a Substance Abuse Counselor in Anaheim, CA: Requirements & Certification

2027 How to Become a Substance Abuse Counselor in Anaheim, CA: Requirements & Certification
2027 Criminology Degree Salary by Industry: Where Graduates Earn the Most

2027 Criminology Degree Salary by Industry: Where Graduates Earn the Most
2027 How to Become a Cost Accountant: Education, Salary, and Job Outlook

2027 How to Become a Cost Accountant: Education, Salary, and Job Outlook
2027 Fastest Online Positive Psychology Degree Programs You Can Finish in Under 2 Years

2027 Fastest Online Positive Psychology Degree Programs You Can Finish in Under 2 Years
2027 What Can You Do with a Criminology Degree? Costs & Job Opportunities

2027 What Can You Do with a Criminology Degree? Costs & Job Opportunities
2027 Online Business Administration Bachelor's Degrees for Adults Over 40

2027 Online Business Administration Bachelor's Degrees for Adults Over 40
2027 Cheapest Way to Get a Teaching Credential in Virginia: Requirements & Certification

2027 Cheapest Way to Get a Teaching Credential in Virginia: Requirements & Certification
2027 Associate to Bachelor's in Accounting: Transfer Pathways Explained

2027 Associate to Bachelor's in Accounting: Transfer Pathways Explained